Back to News
Nov 12, 2025 12:00 PM

New Eye Tech Is Booming For Alcon, Stock Soars

Eye care firm Alcon Inc. (NYSE:ALC) on Tuesday reported third-quarter sales of $2.59 billion, up 6% year over year (up 5% constant currency), marginally missing the consensus of $2.60 billion.

ALC shares are climbing with conviction. View the charts here

“As expected, we saw encouraging topline growth in the third quarter, driven by strong acceleration in equipment,” said David J. Endicott, Alcon’s CEO. “Unity VCS is gaining traction across key markets, and our orderbook remains strong. With PanOptix Pro resonating well with surgeons and early uptake of Tryptyr showing promise, we’re laying the groundwork for a solid 2026.”

Alcon